U.K. Pharmaceuticals & Biotech Growth at Reasonable Price

Oxford Biomedica

Market Cap: UK£320.1m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Diaceutics

Market Cap: UK£107.8m

A diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide.

GSK

Market Cap: UK£56.6b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

AstraZeneca

Market Cap: UK£160.2b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Indivior

Market Cap: UK£1.1b

Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.